# Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers

> **NCT00127803** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 50 (actual)

## Conditions studied

- Clostridium Infections

## Interventions

- **BIOLOGICAL:** Placebo (vaccine diluent)
- **BIOLOGICAL:** Clostridium difficile vaccine
- **BIOLOGICAL:** Clostridium difficile vaccine
- **BIOLOGICAL:** Clostridium difficile vaccine

## Key facts

- **NCT ID:** NCT00127803
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-01
- **Final completion:** 2006-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127803, "Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00127803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*